Stromal Organization as a Predictive Biomarker of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer

J Gastrointest Surg. 2021 Aug;25(8):2116-2118. doi: 10.1007/s11605-021-04920-7. Epub 2021 Feb 5.
No abstract available

Keywords: Locally advanced rectal cancer; Neoadjuvant therapy; Stromal organization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Chemoradiotherapy
  • Humans
  • Neoadjuvant Therapy*
  • Rectal Neoplasms* / drug therapy
  • Rectum
  • Treatment Outcome

Substances

  • Biomarkers